[ad_1] A single oral dose of the investigational antibiotic zoliflodacin performs as well as intramuscular ceftriaxone (Rocephin, Hoffman-LaRoche) for treatment of uncomplicated urogenital and rectal gonococcal infections, a multicenter phase 2 trial …
Read More »
[ad_1] High levels of air pollution are linked to an increased risk of oral cancer, new research has revealed. Scientists have already associated high air pollution with a host of health problems, …
Read More »
[ad_1] Investigators have discovered that an oral tablet for influenza vaccination can protect against infection as well, if not better, than the commercial injectable quadrivalent influenza vaccine. The results of the phase …
Read More »
[ad_1] Shares of Vaxart Inc. VXRT, -0.71% up 44% in trade before marketing Thursday, after the biotech company announced the results of a phase 2 trial that its oral flu vaccine would …
Read More »
[ad_1] Results from a Phase 3 clinical trial, CAPSTONE-2, evaluating Genentech's Balboxavir Marboxil at Roche (OTCQX: RHHBY) in patients at high risk of influenza-related complications have shown therapeutic benefits. The data was …
Read More »
[ad_1] June 30, 2018 A greater proportion of patients treated with lasmiditan were without headache 2 hours after treatment, compared to placebo. SAN FRANCISCO – Lasmiditan is effective and safe for the …
Read More »
[ad_1] The biodegradable patch adheres to the mouth and helps speed up the treatment of painful ulcers. Credit: University of Sheffield A plaster that sticks to the inside of your mouth revolutionizes …
Read More »
[ad_1] Scientists at the University of Sheffield have developed a unique patch using special polymers able to stick to wet surfaces. The patch successfully administers steroids directly to mouth ulcers or lesions …
Read More »